Skip to content
Back to search

NCT04811794Recruiting

Young Survivors at Kantonsspital Aarau, Switzerland

Summary

The Young Survivors at Kantonsspital Aarau project assesses the prevalence and severity of late effects in survivors of childhood and adolescent cancer according to the modified CTCAE criteria prospectively. The clinical data are generated during regular follow-up care visits, the collection starts directly after completion of treatment and is longitudinally.

Inclusion criteria

Group A: Children and adolescents who: • have been treated for cancer in the Division of Oncology-Hematology, Department of Pediatrics, at the Kantonsspital Aarau, • have been diagnosed at age 0-18 years, • are still in regular follow-up care at the Kantonsspital Aarau, • have finished cancer treatment and entered follow-up care, and • signed informed consent Group B: Adolescents and adults who: • fulfill the same inclusion criteria as Group A • are not in regular follow-up care anymore

Exclusion criteria

Childhood Cancer Survivors who: • are in a palliative situation or • have not given consent for further use of medical data

Contacts

The trial team's contact details are shown on request.

See the official trial record
Status
Recruiting
Phase
—
Study type
Observational
Countries
Switzerland
Sponsor
Kantonsspital Aarau(Other)
Protocol no.
AO_2020-00012
Conditions
Childhood Cancer, Late Effects
Interventions
Other

Treatments studied

  • Physical examination, diagnostic tests, laboratory tests
  • Personal history

Locations · 1

  • Aarau, SwitzerlandDivision of Oncology - Hematology, Department of Pediatrics, Kantonsspital AarauRecruiting at this site

In total, worldwide, the only site listed in the registry is recruiting.

Site status per the ClinicalTrials.gov registry (last update posted: August 17, 2022).

This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.

See also

Other versions

These results are indicative and do not replace medical advice — discuss them with your doctor.